VELCADE® receives positive regulatory recommendation in the European Union for subcutaneous administration
26 June 2012 | By Janssen-Cilag International NV
New route of administration provides improved safety and greater convenience...
List view / Grid view
26 June 2012 | By Janssen-Cilag International NV
New route of administration provides improved safety and greater convenience...
9 March 2011 | By Resolute Communications
XEPLION®, has received approval from the European Commission for the treatment of schizophrenia...